Nucleotide Signalling in Breast Cancer
Author Information
Author(s): Yokdang N, Tellez J D, Tian H, Norvell J, Barsky S H, Valencik M, Buxton I L O
Primary Institution: University of Nevada School of Medicine
Hypothesis
Breast cancer cells secrete nucleoside diphosphate kinase (NDPK) to promote angiogenesis through P2Y receptor activation.
Conclusion
sNDPK supports angiogenesis and represents a new therapeutic target for anti-angiogenic therapies.
Supporting Evidence
- Breast cancer cell lines secrete significant amounts of sNDPK-A/B.
- NDPK-B stimulates endothelial cell growth and migration.
- Activation of P2Y receptors by NDPK-B induces VEGFR-2 activation.
- Inhibition of P2Y1R prevents NDPK-B from inducing cell migration.
- Extracellular NDPK-B induces Erk1/2 phosphorylation in endothelial cells.
- NDPK-B's effects on endothelial cells are comparable to those of VEGF.
Takeaway
Breast cancer cells can release a substance that helps blood vessels grow, which might help the cancer spread. Finding ways to stop this could help treat cancer.
Methodology
The study measured NDPK secretion and its effects on endothelial cells using western blot, ELISA, and various pharmacological assays.
Potential Biases
Potential bias in cell line selection and the interpretation of results based on specific receptor interactions.
Limitations
The study primarily focuses on in vitro results, which may not fully represent in vivo conditions.
Participant Demographics
The study used various human breast cancer cell lines derived from women with metastatic disease.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website